| [1] |
Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey[J]. Lancet, 2015, 386(10002): 1465–1471.
|
| [2] |
Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study[J]. Intensive Care Med, 2015, 41(8): 1411–1423.
|
| [3] |
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004, 8(4): R204–R212.
|
| [4] |
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2): R31.
|
| [5] |
Kidney Disease: Improving Global Outcomes (KDIGO), Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury[J]. Kidney Int Suppl, 2012, 2(1): 1–138.
|
| [6] |
Ostermann M, Joannidis M. Acute kidney injury 2016: diagnosis and diagnostic workup[J]. Crit Care, 2016, 20(1): 299.
|
| [7] |
De Rosa S, Samoni S, Ronco C. Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care[J]. Crit Care, 2016, 20(1): 69.
|
| [8] |
Moore E, Tobin A, Reid D, et al. The impact of fluid balance on the detection, classification and outcome of acute kidney injury after cardiac surgery[J]. J Cardiothorac Vasc Anesth, 2015, 29(5): 1229–1235.
|
| [9] |
Lehner GF, Forni LG, Joannidis M. Oliguria and biomarkers of acute kidney injury: star struck lovers or strangers in the night?[J]. Nephron, 2016, 134(3): 183–190.
|
| [10] |
Md Ralib A, Pickering JW, Shaw GM, et al. The urine output definition of acute kidney injury is too liberal[J]. Crit Care, 2013, 17(3): R112.
|
| [11] |
Ostermann M. Diagnosis of acute kidney injury: Kidney Disease Improving Global Outcomes criteria and beyond [J]. Curr Opin Crit Care, 2014, 20(6): 581–587.
|
| [12] |
Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy[J]. Nephrol Dial Transplant, 2012, 27(12): 4263–4272.
|
| [13] |
Lameire N, Vanmassenhove J, Van Biesen W, et al. The cell cycle biomarkers: promising research, but do not oversell them[J]. Clin Kidney J, 2016, 9(3): 353–358.
|
| [14] |
Charlton JR, Portilla D, Okusa MD. A basic science view of acute kidney injury biomarkers[J]. Nephrol Dial Transplant, 2014, 29(7): 1301–1311.
|
| [15] |
Zhou F, Luo Q, Wang L, et al. Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis[J]. Eur J Cardiothorac Surg, 2016, 49(3): 746–755.
|
| [16] |
Zhang A, Cai Y, Wang PF, et al. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis[J]. Crit Care, 2016, 20: 41.
|
| [17] |
Sen S, Godwin ZR, Palmieri T, et al. Whole blood neutrophil gelatinase-associated lipocalin predicts acute kidney injury in burn patients[J]. J Surg Res, 2015, 196(2): 382–387.
|
| [18] |
Quintavalle C, Anselmi CV, De Micco F, et al. Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury[J]. Circ Cardiovasc Interv, 2015, 8(9): e002673.
|
| [19] |
Lin X, Yuan J, Zhao Y, et al. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis[J]. J Nephrol, 2015, 28(1): 7–16.
|
| [20] |
Nisula S, Yang R, Poukkanen M, et al. Predictive value of urine interleukin-18 in the evolution and outcome of acute kidney injury in critically ill adult patients[J]. Br J Anaesth, 2015, 114(3): 460–468.
|
| [21] |
Li W, Yu Y, He H, et al. Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention[J]. Biomed Rep, 2015, 3(4): 509–512.
|
| [22] |
Sabbisetti VS, Waikar SS, Antoine DJ, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes[J]. J Am Soc Nephrol, 2014, 25(10): 2177–2186.
|
| [23] |
Susantitaphong P, Siribamrungwong M, Doi K, et al. Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis[J]. Am J Kidney Dis, 2013, 61(3): 430–439.
|
| [24] |
Ho J, Tangri N, Komenda P, et al. Urinary, plasma, and serum biomarkers′ utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis[J]. Am J Kidney Dis, 2015, 66(6): 993–1005.
|
| [25] |
Petrovic S, Bogavac-Stanojevic N, Lakic D, et al. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery[J]. Biochem Med (Zagreb), 2015, 25(2): 262–271.
|
| [26] |
Liu L, Xie S, Liao X, et al. Netrin-1 pretreatment protects rat kidney against ischemia/reperfusion injury via suppression of oxidative stress and neuropeptide Y expression[J]. J Biochem Mol Toxicol, 2013, 27(4): 231–236.
|
| [27] |
Wohlfhrtova M, Brabcova, Zelezny F, et al. Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft funtion[J]. Transplantation, 2014, 97(2): 176–183.
|
| [28] |
Lombi F, Muryan A, Canzonieri R, et al. Biomarkers in acute kidney injury: evidence or paradigm?[J]. Nefrologia, 2016, 36(4): 339–346.
|
| [29] |
Jiang C, Qi C, Sun K, et al. Diagnostic value of N-acetyl-β-D-glucosaminidase for the early prediction of acute kidney injury after percutaneous nephrolithotripsy[J]. Exp Ther Med, 2013, 5(1): 197–200.
|
| [30] |
Benzer M, Alpay H, Baykan Ö, et al. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children [J]. Ren Fail, 2016, 38(1): 27–34.
|
| [31] |
Andreucci M, Faga T, Riccio E, et al. The potential use of biomarkers in predicting contrast-induced acute kidney injury[J]. Int J Nephrol Renovasc Dis, 2016, 9: 205–221.
|
| [32] |
Zhang Z, Lu B, Sheng X, et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis[J]. Am J Kidney Dis, 2011, 58(3): 356–365.
|
| [33] |
Chen S, Shi JS, Yibulayin X, et al. Cystatin C is a moderate predictor of acute kidney injury in the early stage of traumatic hemorrhagic shock[J]. Exp Ther Med, 2015, 10(1): 237–240.
|
| [34] |
Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury[J]. Crit Care, 2013, 17(1): R25.
|
| [35] |
Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication[J]. Am J Respir Crit Care Med, 2014, 189(8): 932–939.
|
| [36] |
Pilarczyk K, Edayadiyil-Dudasova M, Wendt D, et al. Urinary [TIMP-2]*·[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery[J]. Ann Intensive Care, 2015, 5(1): 50.
|
| [37] |
Kimmel M, Shi J, Wasser C, et al. Urinary [TIMP-2]·[IGFBP7]-novel biomarkers to predict acute kidney injury[J]. Am J Nephrol, 2016, 43(5): 375–382.
|
| [38] |
Bell M, Larsson A, Venge P, et al. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury[J]. Dis Markers, 2015, 2015: 158658.
|
| [39] |
Aguado-Fraile E, Ramos E, Conde E, et al. A pilot study identifying a set of microRNAs as precise diagnostic biomarkers of acute kidney injury[J]. PLoS One, 2015, 10(6): e0127175.
|
| [40] |
Sun SQ, Zhang T, Ding D, et al. Circulating microRNA-188, -30a, and -30e as early biomarkers for contrast-induced acute kidney injury[J]. J Am Heart Assoc, 2016, 5(8): e004138.
|
| [41] |
Liu X, Guan Y, Xu S, et al. Early predictors of acute kidney injury: a narrative review[J]. Kidney Blood Press Res, 2016, 41(5): 680–700.
|